Literature DB >> 2724359

Prediction of clinical course in diabetes using a simple coagulation test.

C R Spillert, V J Milazzo, J A Pastena, E J Lazaro.   

Abstract

Peripheral vascular complications in diabetic patients are extremely variable. It has been suggested that they are related, in part at least, to accelerated blood coagulation. However, a simple test to monitor these changes in coagulability has not been previously described. This article reports that a test in which citrated blood, when incubated with either saline (control) or with endotoxin (to activate the extrinsic pathway) and then subjected to the determination of the recalcification time, can detect minute changes in coagulability. This technique showed that the recalcification times of both saline and endotoxin-incubated blood samples were significantly shorter in a majority of diabetic patients than in controls. These studies substantiate the significant incidence of hypercoagulability in diabetics.

Entities:  

Mesh:

Year:  1989        PMID: 2724359      PMCID: PMC2625897     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Tissue thromboplastin activity of isolated human monocytes.

Authors:  H Prydz; A C Allison
Journal:  Thromb Haemost       Date:  1978-06-30       Impact factor: 5.249

2.  Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage.

Authors:  L J García Frade; H de la Calle; I Alava; J L Navarro; L J Creighton; P J Gaffney
Journal:  Thromb Res       Date:  1987-09-01       Impact factor: 3.944

3.  Thromboplastin as a marker for monocyte differentiation.

Authors:  T Lyberg; I Ivhed; H Prydz; K Nilsson
Journal:  Br J Haematol       Date:  1983-02       Impact factor: 6.998

4.  Shortened endotoxin-activated clotting times in patients with carcinoma.

Authors:  C R Spillert; E J Lazaro
Journal:  Am Surg       Date:  1987-03       Impact factor: 0.688

5.  Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume.

Authors:  A K Rao; R E Goldberg; P N Walsh
Journal:  J Lab Clin Med       Date:  1984-01

6.  Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.

Authors:  R L Jones
Journal:  Diabetes       Date:  1985-09       Impact factor: 9.461

  6 in total
  8 in total

1.  Effect of methylprednisolone on coagulation.

Authors:  H B Pandit; C R Spillert
Journal:  J Natl Med Assoc       Date:  1999-08       Impact factor: 1.798

2.  Contribution of the monocyte to thrombotic potential.

Authors:  C R Spillert; E J Lazaro
Journal:  Agents Actions       Date:  1991-09

3.  Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.

Authors:  C R Spillert; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1995-09       Impact factor: 1.798

4.  Altered coagulability: an aid to selective breast biopsy.

Authors:  C R Spillert; M R Passannante; J E Salzer-Pagan; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1993-04       Impact factor: 1.798

5.  Role of platelet age in assessment of coagulation.

Authors:  C R Spillert; C S Lee; E E Federici; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1995-12       Impact factor: 1.798

6.  In vitro effect of hirudin on recalcification time.

Authors:  J Hirsh; C R Spillert; E P Delle Donne; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

7.  Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.

Authors:  C R Spillert; S Sun; M A Miller; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798

8.  Modified recalcification time: a global coagulation screening test.

Authors:  C R Spillert; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1993-08       Impact factor: 1.798

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.